IGFBP2 and neoplasm: In conclusion, we demonstrate significantly elevated serological levels of IGFBP2 proportional to the tumor size and stage in gastric cancer patients, and show that high serum IGFBP2 level is an independent prognostic factor predicting poor survival in patients with gastric cancer.